Erik T. Askevold

1.8k total citations · 1 hit paper
25 papers, 1.4k citations indexed

About

Erik T. Askevold is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Erik T. Askevold has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 13 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Erik T. Askevold's work include Cardiac Fibrosis and Remodeling (11 papers), Signaling Pathways in Disease (4 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Erik T. Askevold is often cited by papers focused on Cardiac Fibrosis and Remodeling (11 papers), Signaling Pathways in Disease (4 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Erik T. Askevold collaborates with scholars based in Norway, United Kingdom and Sweden. Erik T. Askevold's co-authors include Pål Aukrust, Arne Yndestad, Lars Gullestad, Thor Ueland, Christen P. Dahl, Geir Christensen, Ståle H. Nymo, Trine Ranheim, Leif Erik Vinge and Alexandra Vanessa Finsen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Cardiovascular Research.

In The Last Decade

Erik T. Askevold

25 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury

2013 435 citations Øystein Sandanger, Trine Ranheim et al. Cardiovascular Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik T. Askevold Norway	22	649	641	262	224	181	25	1.4k
Dirk Jan van Veldhuisen Netherlands	14	496 0.8×	1.2k 1.8×	189 0.7×	232 1.0×	117 0.6×	36	1.7k
Go Haraguchi Japan	20	393 0.6×	442 0.7×	352 1.3×	248 1.1×	180 1.0×	55	1.4k
Koichi Sohmiya Japan	20	487 0.8×	506 0.8×	102 0.4×	261 1.2×	136 0.8×	66	1.3k
Massimo Puato Italy	25	396 0.6×	744 1.2×	267 1.0×	427 1.9×	255 1.4×	61	2.0k
Yuichi Nakamura Japan	24	544 0.8×	526 0.8×	139 0.5×	394 1.8×	129 0.7×	103	1.8k
Cory R. Trankle United States	23	522 0.8×	1.1k 1.6×	230 0.9×	401 1.8×	209 1.2×	84	1.7k
Yuichiro Kashima Japan	11	541 0.8×	364 0.6×	174 0.7×	289 1.3×	97 0.5×	28	980
Dimitrios Stakos Greece	27	450 0.7×	825 1.3×	631 2.4×	286 1.3×	316 1.7×	76	2.2k
Ignacio M. Seropián Argentina	23	1.1k 1.7×	1.1k 1.7×	495 1.9×	461 2.1×	273 1.5×	52	2.3k
Suzanne L. Advani Canada	26	914 1.4×	476 0.7×	156 0.6×	335 1.5×	203 1.1×	50	2.1k

Countries citing papers authored by Erik T. Askevold

Since Specialization

Citations

This map shows the geographic impact of Erik T. Askevold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik T. Askevold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik T. Askevold more than expected).

Fields of papers citing papers by Erik T. Askevold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik T. Askevold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik T. Askevold. The network helps show where Erik T. Askevold may publish in the future.

Co-authorship network of co-authors of Erik T. Askevold

This figure shows the co-authorship network connecting the top 25 collaborators of Erik T. Askevold. A scholar is included among the top collaborators of Erik T. Askevold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik T. Askevold. Erik T. Askevold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abraityte, Aurelija, Leif Erik Vinge, Erik T. Askevold, et al.. (2017). Wnt5a is elevated in heart failure and affects cardiac fibroblast function. Journal of Molecular Medicine. 95(7). 767–777. 57 indexed citations

Nymo, Ståle H., Pål Aukrust, John Kjekshus, et al.. (2017). Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure. JACC Heart Failure. 5(4). 256–264. 25 indexed citations

Abraityte, Aurelija, Ida G. Lunde, Erik T. Askevold, et al.. (2017). Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy. Scientific Reports. 7(1). 3490–3490. 28 indexed citations

Gregersen, Ida, Øystein Sandanger, Erik T. Askevold, et al.. (2017). Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation. PLoS ONE. 12(11). e0188387–e0188387. 23 indexed citations

Ueland, Thor, Christen P. Dahl, Erik T. Askevold, et al.. (2016). Low Circulating Levels of Mitochondrial and High Levels of Nuclear DNA Predict Mortality in Chronic Heart Failure. Journal of Cardiac Failure. 22(10). 823–828. 21 indexed citations

Askevold, Erik T., Lars Gullestad, Ståle H. Nymo, et al.. (2015). Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). PLoS ONE. 10(8). e0133970–e0133970. 24 indexed citations

Finsen, Alexandra Vanessa, Thor Ueland, Ivar Sjaastad, et al.. (2014). The Homeostatic Chemokine CCL21 Predicts Mortality in Aortic Stenosis Patients and Modulates Left Ventricular Remodeling. PLoS ONE. 9(11). e112172–e112172. 20 indexed citations

Askevold, Erik T., Lars Gullestad, Christen P. Dahl, et al.. (2014). Interleukin-6 Signaling, Soluble Glycoprotein 130, and Inflammation in Heart Failure. Current Heart Failure Reports. 11(2). 146–155. 38 indexed citations

Broch, Kaspar, Erik T. Askevold, Erik Gjertsen, et al.. (2014). The Effect of Rosuvastatin on Inflammation, Matrix Turnover and Left Ventricular Remodeling in Dilated Cardiomyopathy: A Randomized, Controlled Trial. PLoS ONE. 9(2). e89732–e89732. 10 indexed citations

10.

Nesheim, Britt‐Ingjerd, et al.. (2014). Long-acting reversible contraception for adolescents and young adults – A cross-sectional study of women and general practitioners in Oslo, Norway. The European Journal of Contraception & Reproductive Health Care. 19(3). 194–202. 13 indexed citations

11.

Gregersen, Ida, Mona Skjelland, Sverre Holm, et al.. (2013). Increased Systemic and Local Interleukin 9 Levels in Patients with Carotid and Coronary Atherosclerosis. PLoS ONE. 8(8). e72769–e72769. 42 indexed citations

12.

Engebretsen, Kristin V. T., Ida G. Lunde, Mari E. Strand, et al.. (2013). Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli. FEBS Journal. 280(10). 2382–2398. 85 indexed citations

13.

Prohászka, Zoltán, Lea Munthe‐Fog, Thor Ueland, et al.. (2013). Association of Ficolin-3 with Severity and Outcome of Chronic Heart Failure. PLoS ONE. 8(4). e60976–e60976. 36 indexed citations

14.

Nymo, Ståle H., Johannes Hulthe, Thor Ueland, et al.. (2013). Inflammatory Cytokines in Chronic Heart Failure: Interleukin-8 is Associated with Adverse Outcome. Results from CORONA. European Journal of Heart Failure. 16(1). 68–75. 64 indexed citations

15.

Sandanger, Øystein, Trine Ranheim, Leif Erik Vinge, et al.. (2013). The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury. Cardiovascular Research. 99(1). 164–174. 435 indexed citations breakdown →

16.

Gullestad, Lars, Stein Ørn, Kenneth Dickstein, et al.. (2012). Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarction. International Journal of Cardiology. 168(1). 212–218. 24 indexed citations

17.

Askevold, Erik T., Lars Gullestad, Svend Aakhus, et al.. (2012). Secreted Wnt Modulators in Symptomatic Aortic Stenosis. Journal of the American Heart Association. 1(6). e002261–e002261. 35 indexed citations

18.

Ueland, Thor, Asbjørn Svardal, Erik Øie, et al.. (2012). Disturbed carnitine regulation in chronic heart failure — Increased plasma levels of palmitoyl-carnitine are associated with poor prognosis. International Journal of Cardiology. 167(5). 1892–1899. 57 indexed citations

19.

Nymo, Ståle H., Thor Ueland, Erik T. Askevold, et al.. (2011). The association between neutrophil gelatinase‐associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*. Journal of Internal Medicine. 271(5). 436–443. 55 indexed citations

20.

Askevold, Erik T., Halvor Næss, & Lars Thomassen. (2007). Predictors for Recanalization After Intravenous Thrombolysis in Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 16(1). 21–24. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact